Full-Time

Manager – Digital Finance Solutions

Confirmed live in the last 24 hours

Deadline 7/17/25
Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

No salary listed

Senior

Chennai, Tamil Nadu, India

Hybrid

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
SAP Products
Requirements
  • Bachelor’s degree.
  • 5+ years of hands-on experience with SAP configurations in SAP Finance module specifically in one of more areas among e-Invoicing & Tax; OpenText document management, Credit to Cash and SAP Banking.
  • Ability to define and understand business requirements, design SAP solutions, and configure the system to meet legal and business requirements.
  • Ability to work with middleware team or ABAP/web developers to design, develop, and test interfaces or system enhancements.
  • High degree of acumen and deep process knowledge in Finance space.
Responsibilities
  • Demonstrate a broad understanding of SAP Finance process knowledge to evaluate the changes required based on Business requirements.
  • Collaborate with business users to understand legal/business requirements, design appropriate solutions, and provide estimates.
  • Configure SAP Finance system to achieve the desired results and perform testing as needed; Design enhancements to SAP standard solution or new custom solution, create functional specifications, and collaborate with SAP developers to implement the solution.
  • Develop strong relationships at all levels of the organization. Collaborate and communicate with stakeholders at different levels, different cultural backgrounds and in different geographical regions.
  • Lead a team of consultants and collaborate closely with regional and global Digital teams to deliver solutions on time and on budget.
Desired Qualifications
  • Extensive integration experience with other SAP functional modules as well as other edge systems.
  • Previous consulting experience of at least 3 full life cycle projects implementing SAP Finance solutions. Experience with OpenText document management is a plus.
  • Familiarity with common middleware technologies, IDOC, SFTP, API, etc.
  • Basic understanding of SAP table structures and table relationships.
  • Familiarity with Microsoft Office tools.
  • Working as part of a team on major, complex business change / IT programs.
  • Show ability to lead, build teams, and manage / coordinate complex activities across multiple teams.
  • Knowledge of the software development lifecycles.

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines and specialized medicines for conditions like cancer. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved communities, and continues to grow its product offerings with new treatments and approvals.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • €3.3 billion bond offering provides capital for research initiatives or acquisitions.
  • Starboard Value's $1 billion stake suggests potential strategic changes to enhance shareholder value.
  • Backing Promise Bio aligns with expanding into new therapeutic areas like autoimmune diseases.

What critics are saying

  • Increased competition from emerging biotech companies could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses a risk to Pfizer's revenue streams.
  • Shift towards AI-driven drug discovery may disrupt traditional R&D processes at Pfizer.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer's investment in AI disease models enhances drug discovery and development.
  • Pfizer's strategic interest in TCR-based immunotherapies diversifies its oncology portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Stroock & Stroock & Lavan LLP
May 20th, 2025
Pfizer Completes €3.3 Billion Bond Offering

Simpson Thacher represented the underwriters, led by Goldman Sachs & Co. LLC, BNP PARIBAS, HSBC, Mizuho, among others in connection with a registered offering of €3.3 billion in Notes by Pfizer, Inc.’s (“Pfizer”) wholly-owned subsidiary, Pfizer Netherlands International Finance B.V. (the “Issuer”). The Notes were issued in four series with maturities ranging from 2029 to 2045, with proceeds intended to be used for general corporate purposes. The Notes are fully and unconditionally guaranteed on a senior unsecured basis by Pfizer.

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.